Electromed has delivered strong revenue growth and margin improvement but faces a highly competitive, fragmented market for its SmartVest product. ELMD lacks a durable moat, with rivals like Tactile ...
NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three and six ...
Electromed Inc. (ELMD) reported strong financial results for the second quarter of fiscal year 2026, surpassing earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.32, ...
Net revenues increased 16.3% to a record $18.9 million in Q2 FY 2026, from $16.3 million in the second quarter of the prior fiscal year, led by an 18.4% increase in the core homecare market. Operating ...
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for ...
NEW PRAGUE, Minn., January 27, 2026--(BUSINESS WIRE)--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that ...
Practical strategies for turning tutorials into active, inclusive learning spaces, from designing hands-on activities and valuing student contributions to building rapport and providing effective ...
Electromed develops and markets medical devices in the respiratory care field. Its main product is the SmartVest System, which delivers High Frequency Chest Wall Oscillation (HFCWO) therapy to help ...
Electromed, Inc. (NYSE:ELMD) is one of the 11 Best Long Term Low Risk Stocks to Invest in. Analysts maintain a Buy rating stock amid strong Q3 earnings and the company’s inclusion in the Russell 2000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results